dr reddys laboratories

Top stock market recommendations: Aakash K Hindocha, Deputy Vice President - WM Research, Nuvama Professional Clients Group has picked Godrej Properties, V-Mart Retail, and Dr Reddy's Laboratories as the top stock recommendations for May 7, 2026.

A Bengaluru court denied bail to Dr. Mahendra Reddy GS, arrested for allegedly murdering his wife, Kruthika Reddy, by administering an overdose of anaesthesia. Police recovered digital evidence, including incriminating messages, suggesting Reddy planned the murder due to marital discord and his wife's ill health.

Pharma major dr reddys laboratories on Wednesday reported 52.49 per cent jump in net profit at Rs 550.39 crore for the quarter ended June 30, 2014.

Dr Reddy's Laboratories Ltd, India's second-largest drugmaker by sales, on Tuesday posted a 25 per cent rise in quarterly net profit, but fell short of analysts' estimates due to a rise in expenses.

Dr Reddy's Laboratories has announced the launch of Bivalirudin, a injection for the US market. The injection will be a generic version of Angiomax. The drug will be available in packages of 10 single-dose vials.

Indian equity markets experienced a significant downturn, with Sensex and Nifty shedding nearly 2% on Wednesday. A sharp rise in crude oil prices, fueled by escalating West Asian tensions, dampened investor sentiment. Persistent foreign fund outflows and selling in banking stocks further contributed to the market's decline.

Dr Reddy's Laboratories on Thursday said it has inked a pact with US-based biotechnology firm Amgen to market its three drugs used to treat heart diseases and cancer in India.

City-based drugmaker Dr Reddy's Laboratories has acquired Habitrol brand, a nicotine replacement therapy transdermal patch, from Novartis Consumer Health Inc.

A host of Andhra Pradesh businessmen and leading politicians were among those who bid adieu to Dr Reddy's Laboratories founder chairman Anji Reddy before he was cremated at the Panjagutta cremation grounds on Saturday morning.

After shrugging off its proposed joint venture with Fujifilm which was a non-starter, Dr Reddy's Laboratories Limited is back on the drawing board and is keen to make a fresh foray into the Japanese market.

Drug firm Dr Reddy's Laboratories today reported a 66.58 per cent rise in its net profit to Rs 570.89 crore for the quarter ended March 31, 2013 mainly on account of robust sales across all segments.

Buzz about Dr Reddy's Laboratories (DRL) founder-chairman Dr K Anji Reddy hanging up his boots just got stronger. On Friday, for perhaps the first time in the company's history.

Dr Reddy's Laboratories (DRL) on Tuesday said its net profit grew by 67% to Rs 571 crore in the fourth quarter ended March 31 on better performance across all segments.

Dr Reddy's Laboratories is hoping to replicate its success with generic drugs with biosimilars that are growing at a fast pace.

Just days after an accidental gas leak proved fatal for two workers at its bulk drugs facility in Bollaram, a major disaster was averted at Dr Reddy's Laboratories after a fire broke out at one of its production units at Bachupally on Monday morning.

The portfolio consists of products that are being divested by Teva as a precondition to its closing of the acquisition of Allergan's generics business, the Hyderabad-based firm said. The combined sales of the branded versions of the products in the US is around $3.5 billion.

The Directorate of Factories, Andhra Pradesh, has filed a second case against pharma major Dr Reddy's Laboratories over alleged safety-related lapses at its US FDA-certified manufacturing facilities at Bollaram, in Medak District of Andhra Pradesh.

Dr Reddy's Laboratories will contest the patent infringement case filed against it by the global pharmaceutical giant Pfizer over its cholesterol lowering drug atorvastatin, said a company spokesperson on Wednesday.

Just days after an accidental gas leak proved fatal for two workers at its bulk drugs facility in Bollaram, a major disaster was averted at Dr Reddy's Laboratories after a fire broke out at one of its production units at Bachupally on Monday morning.

Dr Reddy's Laboratories has launched a generic version of Roche's anti-osteoporosis drug Boniva in the US market

US-based biopharmaceutical company Cellceutix Corporation on Tuesday announced that the Hyderabad-based pharma giant Dr Reddy's Laboratories (DRL) will manufacture formulations for its Brilacidin drug that will be used in the treatment of ophthalmic and otitis media infections.

Even as Dr Reddy's Laboratories is gearing up to submit Phase-3 clinical trials data of the single-dose Russian vaccine Sputnik Light to the Drugs Controller General of India (DCGI) in November, it is also planning to approach the regulator for permission to conduct separate Sputnik Light trials for children as well as a booster for adults.

Anji Reddy, the pharmaceutical industry pioneer who helped establish India's reputation as a supplier of inexpensive medicines to the world, died in Hyderabad on Friday after prolonged illness. The 72-year-old was battling cancer.